TNXP — TONIX PHARMACEUTICALS HLDG C
As of Q2 2026, 24 SEC-registered investment managers reported holding TNXP (TONIX PHARMACEUTICALS HLDG C) in their latest 13F filings, with a combined reported value of $77.23M across 6.07M shares. That is +90.3% by share count (+2.88M shares) versus the previous quarter, while reported value moved +76.8%. Ownership is concentrated: the five largest holders account for 79.5% of reported value and the top ten for 93.8%.
Compared with the prior quarter, 3 opened new positions, 16 added to existing stakes, 3 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
TNXP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.40M | $17.84M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 1.17M | $14.89M | 0.02% | Add |
| Millennium Management history | Q2 2026 | 966.93K | $12.34M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 882.60K | $11.26M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 673.61K | $10.52M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 395.26K | $5.04M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 287.06K | $3.66M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 231.68K | $2.96M | 0.00% | Hold |
| Balyasny Asset Management history | Q2 2026 | 132.59K | $1.69M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 120.39K | $1.54M | 0.00% | Add |
| Davidson Kempner Capital Management history | Q4 2025 | 90.01K | $1.41M | 0.02% | New |
| Goldman Sachs Group history | Q2 2026 | 98.36K | $1.26M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 93.55K | $1.19M | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2022 | 5.01M | $1.15M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 60.98K | $778.07K | 0.00% | Hold |
| Charles Schwab Investment Management history | Q2 2026 | 52.61K | $671.34K | 0.00% | Add |
| Wellington Management Group history | Q3 2025 | 26.46K | $639.39K | 0.00% | New |
| BNY Mellon history | Q2 2026 | 41.75K | $532.78K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 37.69K | $480.94K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 28.81K | $367.64K | 0.00% | New |
New Positions (Q2 2026)
- Two Sigma Investments 28.81K sh · $367.64K
- JPMorgan Chase & Co 6.11K sh · $77.92K
- PNC Financial Services 168 sh · $2.14K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | 69.58K | 420.45K | 681.53K | 884.88K | 968.18K | 1.40M |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 620.03K | 125.41K | 1.17M |
| Millennium Management | 228.56K | — | 25.61K | 140.41K | 406.49K | 13.30K | — | — | 18.72K | 27.04K | 114.11K | 36.86K | 8.88K | 52.73K | 22.95K | 219.67K | 966.93K |
| AQR Capital Management | 89.18K | 1.02M | — | — | — | — | — | — | — | — | — | — | — | — | 20.02K | 161.21K | 882.60K |
| Geode Capital Management | 7.42M | 7.20M | 7.62M | 132.85K | 343.96K | 371.85K | 533.51K | 85.36K | 126.30K | 106.61K | 398.71K | 62.04K | 175.21K | 200.93K | 271.90K | 313.29K | 395.26K |
| Citadel Advisors | 622.18K | 219.50K | 232.53K | 58.90K | 26.16K | — | — | — | — | — | — | — | 7.08K | — | 39.80K | 511.81K | 287.06K |
| UBS Group AG | 11 | 334.18K | 254.95K | 24.07K | 356 | 67.53K | 25.80K | — | — | — | — | 19.97K | 22.46K | 51.58K | 91.46K | 231.68K | 231.68K |
| Balyasny Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 185.35K | 313.08K | 132.59K |
| Northern Trust Corp | 3.26M | 3.84M | 4.14M | 24.79K | 50.38K | 50.38K | 101.89K | 16.30K | 16.30K | 16.30K | 92.55K | 13.07K | 164.02K | 169.69K | 174.89K | 100.13K | 120.39K |
| Goldman Sachs Group | 616.13K | 612.44K | 424.85K | 10.89K | 34.18K | — | — | — | — | — | — | — | — | 12.72K | 26.81K | 53.05K | 98.36K |
| Fidelity Management & Research (FMR) | 599 | — | 22.12K | 2.13K | — | 1 | — | — | 6 | 25 | — | — | 12.75K | 45.47K | 1.50K | 1.74K | 93.55K |
| Bank of America Corp | 117.00K | 1.63M | 1.42M | 34.62K | 20.21K | 5.32K | 264 | 26.37K | 8 | 39 | 9 | 5.76K | 3.50K | 4.65K | 30.31K | 60.96K | 60.98K |
| Charles Schwab Investment Management | 881.73K | 1.09M | 1.25M | — | — | — | — | — | — | — | — | — | 21.73K | 26.79K | 33.40K | 29.79K | 52.61K |
| BNY Mellon | 1.00M | 1.12M | 1.32M | — | — | — | — | — | — | — | — | — | 17.75K | 20.14K | 24.06K | 30.43K | 41.75K |
| Invesco Ltd | 105.38K | 115.30K | 138.28K | — | — | — | — | — | — | — | — | — | — | — | — | 15.27K | 37.69K |
| Two Sigma Investments | 21.00K | — | — | — | 201.65K | 21.20K | 60.19K | 12.75K | — | — | — | — | — | — | — | — | 28.81K |
| Wells Fargo & Co | 14.29K | 220.71K | 57.26K | 125 | 286 | 392 | 421 | 74 | 130 | 183 | 458 | — | 4.86K | 7.19K | 15.43K | 8.63K | 15.42K |
| Morgan Stanley | 262.45K | 877.36K | 542.53K | 886.72K | 933.57K | 214.90K | 711.97K | 10.46K | 9.09K | 7.96K | 7.84K | 2.68K | 18.93K | 15.68K | 42.04K | 17.27K | 15.24K |
| Deutsche Bank AG | 374.15K | 269.41K | 240.46K | 77.92K | — | — | — | — | — | — | — | — | 5.14K | 5.90K | 507 | 12.16K | 12.55K |
| Citigroup Inc | 46.22K | 128.65K | 92.12K | 6.90K | 115 | — | — | 15 | — | — | — | 122 | 2.54K | 249 | 341 | 2.90K | 6.73K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details